Efficacy and Safety of A Second Generation Biodegradable ‐Polymer Sirolimus‐Eluting Stent: One Year Results of The CREDIT 2 Trial

ConclusionsThe 2nd generation BP‐DES (EXCEL 2) was non‐inferior to the 1st generation BP‐DES (EXCEL) for the primary endpoint of in‐stent LL at 9 months.Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT02057978.This article is protected by copyright. All rights reserved.

Source: Cardiovascular Therapeutics - February 1, 2018 Category: Cardiology Authors: Kai Xu, Yaling Han, Bo Xu, Yuejin Yang, Geng Wang, Hui Li, Yong Sun, Ling Tao, Haichang Wang, Zuyi Yuan, Liu Huiliang, Jinghua Liu, Yongping Jia, Genshan Ma, Guosheng Fu, Xiaodong Li, Shuren Li, Shouli Wang, Kui Pu, Tags: Original Research Article Source Type: research